Chordate Medical Holding Management
Management criteria checks 3/4
Chordate Medical Holding's CEO is Anders Weilandt, appointed in Jun 2017, has a tenure of 7.58 years. directly owns 1.43% of the company’s shares, worth SEK198.80K. The average tenure of the management team and the board of directors is 8.1 years and 7.8 years respectively.
Key information
Anders Weilandt
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 7.6yrs |
| CEO ownership | 1.4% |
| Management average tenure | 8.1yrs |
| Board average tenure | 7.8yrs |
Recent management updates
CEO
Anders Weilandt (63 yo)
7.6yrs
Tenure
Mr. Anders Weilandt served as Director at Neola Medical AB (formerly known as GPX Medical AB (publ)) since May 2022 until 2024. Mr. Weilandt serves as the Chief Executive Officer at Chordate Medical Holdin...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & MD | 7.6yrs | no data | 1.43% SEK 219.8k | |
| Chief Financial Officer | 7.3yrs | no data | 0.036% SEK 5.5k | |
| CTO and Head of R&D | 13yrs | no data | 0.010% SEK 1.6k | |
| Chief Scientific Officer and Clinical Research & Medical Director | no data | no data | 0.31% SEK 47.1k | |
| Sales & Marketing Manager | 8.6yrs | no data | no data |
8.1yrs
Average Tenure
63yo
Average Age
Experienced Management: CMH's management team is seasoned and experienced (8.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 10.6yrs | SEK 100.00k | 5.24% SEK 807.0k | |
| Independent Director | 7.8yrs | SEK 100.00k | no data | |
| Independent Chairman | 10.2yrs | SEK 180.00k | 1.36% SEK 209.3k | |
| Independent Director | 3.3yrs | SEK 100.00k | 5.96% SEK 917.2k | |
| Vice Chairman | 1.7yrs | SEK 140.00k | no data |
7.8yrs
Average Tenure
61yo
Average Age
Experienced Board: CMH's board of directors are considered experienced (7.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/23 18:49 |
| End of Day Share Price | 2025/01/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Chordate Medical Holding AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|